TrialsgrambetaRCTs are beautiful

CATIE

2005

Clinical Antipsychotic Trials of Intervention Effectiveness

In 1,493 patients with chronic schizophrenia, olanzapine, quetiapine, risperidone or ziprasidone achieved the same time to discontinuation as perphenazine, with most patients stopping treatment by 18 months.

Result

Primary endpoint: Time to all-cause discontinuation

~74% discontinued within 18 months across arms; olanzapine had the longest time-to-discontinuation but most weight gain.

Original publication
Subtopic
Pharmacology context
Design
Multi-phase pragmatic RCT, USA
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Lieberman JA, et al. N Engl J Med. 2005;353(12):1209-1223.doi 10.1056/NEJMoa051688

Discussion & critique

Backdrop for why psychosocial augmentation matters: even with modern antipsychotics, real-world adherence is poor.